Prostate cancer cases spike in this US state as doctors share likely reason
Cases of prostate cancer are on the rise in California, according to new research.
A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.
The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the JAMA-published research revealed.
Common Cancer Type Could Be Detected With New Blood Test
Although cases rose, prostate cancer mortality rates declined 2.6% per year from 2004 to 2012, and plateaued from 2012 to 2021. These trends were similar across age, race, ethnicity and region, the researchers found.
The rising cases correspond with a change in guidelines for PSA (prostate-specific antigen) testing, in which the U.S. Preventative Services Task Force (USPSTF) stopped recommending the screenings in 2012, according to the UCSF press release.
Read On The Fox News App
The guidelines were changed in order to reduce the number of prostate cancer patients who were treated with "potentially harmful interventions" for non-threatening forms of the disease.
Men's Cancer Deaths Expected To Spike More Than 90% By 2050, Study Finds
According to UCSF, prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths.
Most prostate cancer tumors, however, are low-grade and "never spread" — and the PSA screening "does not differentiate between aggressive or non-aggressive tumors, leading many men to be diagnosed with cancers that would not hurt them in the long run," the release stated.
"On the other hand, if screening isn't done, timely diagnosis of more advanced cancers can be missed – those cancers might have been successfully treated if found early," UCSF noted.
The freeze in screenings "unfortunately may have led to one of the largest subsequent rises in incidence of distant stage disease," according to the researchers.
UCSF wrote that these findings "reinforce the need for screening that can identify potentially fatal tumors without raising false alarms about ones that pose no threat to the patient."
"Figuring out the best way to screen for prostate cancer continues to be a challenge for researchers and doctors," lead study author Dr. Erin L. Van Blarigan, UCSF associate professor of epidemiology, biostatistics and urology, said in a statement.
Click Here To Sign Up For Our Health Newsletter
"Without screening, the number of men diagnosed with advanced prostate cancer – when treatments are less effective – increases fast."
Fox News senior medical analyst Dr. Marc Siegel, who was not involved in the study, also called out the need for regular screenings.
For more Health articles, visit www.foxnews.com/health
"[Screenings] decreased in many areas, including California, as the U.S. Preventive Services Task Force recommended against PSA as a regular screening tool, which I always disagreed with," he told Fox News Digital. "Especially as MRI advanced, so not all elevated PSA automatically meant a biopsy."
Based on the increase in prostate cancer cases across all ages, Siegel emphasized the need to "diagnose it early for better outcomes."
Siegel suggested that the increase in cases could also be due to a variety of factors, including the obesity epidemic, ultraprocessed foods and an increase in alcohol consumption and fatty foods.
David R. Wise, MD, PhD, urologic oncologist and the service chief of the Genitourinary Medical Oncology Program at NYU Langone Perlmutter Cancer Center, also reacted to this rise in cases.
"The increasing incidence of metastatic prostate cancer in California in the 2010s is consistent with reports by others, including the American Cancer Society," Wise, who was not involved in the research, told Fox News Digital.
"It likely reflects the aftermath of diminished prostate cancer screening. A return to prostate cancer screening will likely reverse this effect."
"Optimized screening, enhanced by MRI and novel blood-based biomarkers, is now available and is poised to spare men with low risk disease from unnecessary treatment while ensuring early detection for men with aggressive cancer," he added.Original article source: Prostate cancer cases spike in this US state as doctors share likely reason
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Where you live may affect your risk of dementia, UCSF study finds
In a major national study led by UCSF researchers, dementia rates among older Americans were found to vary sharply by region, with the Southeast facing the greatest burden and the Bay Area's broader region faring somewhat better. Published Monday in JAMA Neurology, the study drew on health records from more than 1.2 million veterans age 65 and older, served by the Veterans Health Administration, the largest integrated health system in the U.S. It is one of the largest efforts to date to chart geographic patterns in dementia, and its findings could guide how public health officials respond to one of the most pressing challenges of an aging population. Using the Mid-Atlantic region — including states such as Pennsylvania and Virginia — as the baseline, UCSF researchers found that dementia incidence was 25% higher in the Southeast, which includes Kentucky, Tennessee, Alabama and Mississippi. Rates in the Northwest and Rocky Mountains were 23% higher, and in the South, including Texas and New Mexico, 18% higher. California was part of the Southwest region, which showed a 13% higher rate of dementia compared to the Mid-Atlantic. The Northeast, including New York and New England states, was 7% higher. 'The study underscores the need to understand regional differences in dementia and the importance of region-specific prevention and intervention efforts,' said senior author Dr. Kristine Yaffe, a professor at UCSF and the San Francisco VA Health Care System. 'Quality of education, early life conditions, and environmental exposures may be among those factors,' she said. The authors noted some limitations in the study, including that veterans 'may not be entirely representative of the general U.S. population, particularly regarding sex and gender distribution,' and have a higher prevalence of dementia risk factors, including traumatic brain injury, post-traumatic stress and depression. However, despite adjusting for race, age, cardiovascular disease and rurality, the regional patterns remained, highlighting the importance of local context in both risk and response, the authors added.
Medscape
4 hours ago
- Medscape
Sacroiliac MRI Lesions Set Apart axSpA and Other Back Pain
The analysis of structural lesions in sacroiliac joints using MRI showed distinct patterns of structural changes across multiple groups, with patients with axial spondyloarthritis (axSpA) showing higher rates of erosions and fatty lesions than other groups without axSpA. Inflammatory and structural lesions occurred simultaneously in those with axSpA. METHODOLOGY: Researchers assessed differences in the structural lesions appearing on sacroiliac joint MRIs in 172 participants (mean age, 30.1-34.3 years) from two projects comparing patients with axSpA with those without. They included patients with axSpA (n = 47) and those without axSpA comprising patients with chronic back pain (n = 47), women with postpartum back pain (n = 7), runners (n = 24), and healthy individuals (n = 47). Two trained, calibrated readers independently inspected the sacroiliac joint MRIs for erosions, fatty lesions, sclerosis, and ankylosis. A scoring system similar to that of the Spondyloarthritis Research Consortium of Canada scoring method was used for the assessment. Several structural lesion cutoffs were identified and tested as suggested by two working groups, with specific definitions for three or more erosions, three or more fatty lesions, and five or more erosions and/or fatty lesions. The frequency of patients meeting the cutoffs was assessed within different subgroups. TAKEAWAY: Structural lesions were identified in 79% of patients with axSpA and 13% of those without axSpA, with erosions (75% vs 9%) and fatty lesions (40% vs 4%) showing the most marked differences and sclerosis (13% vs 3%) and ankylosis (15% vs 2%) showing smaller group differences. Erosions were also prevalent in women with postpartum back pain (57%), and fatty lesions were the most prevalent in healthy individuals (6%). Significant differences were noted across groups for fatty lesions ( P < .001), erosions ( P < .001), and ankylosis ( P = .016); however, sclerosis showed no significant variation. The proposed cutoff definitions performed well in differentiating axSpA from non-axSpA. < .001), erosions ( < .001), and ankylosis ( = .016); however, sclerosis showed no significant variation. The proposed cutoff definitions performed well in differentiating axSpA from non-axSpA. In the axSpA group, an overlap of 72%-79% was observed between structural lesions and inflammation, while non-axSpA subgroups showed a significantly lower rate of overlap. However, 4%-29% of patients in the non-SpA subgroup compared with only 6% in the axSpA group had structural lesions without inflammation. IN PRACTICE: "We are convinced that if structural lesions ought to be part of axSpA classification criteria, the implementation of cut-offs for these lesions should be considered. Nevertheless, for a comprehensive understanding of the possible added value of structural lesions, it is crucial to look at the prevalence of structural lesions in the absence of inflammation," the authors wrote. SOURCE: This study was led by Zohra Kerami, Amsterdam UMC Locatie AMC, Amsterdam, the Netherlands. It was published online on May 28, 2025, in RMD Open . LIMITATIONS: The sample sizes were notably small for some subgroups. Additionally, comprehensive clinical and demographic information was lacking for healthy individuals, women with postpartum back pain, and runners. Data on previous pregnancies and the interval between MRI and delivery were not collected systematically, which limited the analysis of pregnancy-related effects. DISCLOSURES: This study did not receive any specific funding. Few authors reported receiving consultancy fees, research support, and/or speaking fees and honoraria for lectures or participation in advisory boards from various pharmaceutical companies. One author reported being an associate editor and another reported being an owner of Joint Imaging BV.
Washington Post
7 hours ago
- Washington Post
Mothers report worse mental health in new report
More American mothers reported worse mental health in 2023 than in 2016 in a national survey, though many said they were in good health, according to a study in JAMA Internal Medicine. Using data from the National Survey of Children's Health, researchers analyzed self-reported mental health ratings from some 198,000 mothers with children age 17 and younger. In 2023, 26 percent of the mothers who responded said their mental health was 'excellent,' compared with 38 percent of mothers in 2016. While 19 percent of mothers reported good mental health in 2016, some 26 percent said the same in 2023.
